BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vine LJ, Sieberhagen C, Cramp ME. Diagnosis and management of hepatitis C. Br J Hosp Med (Lond) 2015;76:625-30. [PMID: 26551491 DOI: 10.12968/hmed.2015.76.11.625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Hassanin TM, Abdelraheem EM, Abdelhameed S, Abdelrazik M, Fouad YM. Detection of hepatitis C virus core antigen as an alternative method for diagnosis of hepatitis C virus infection in blood donors negative for hepatitis C virus antibody. Eur J Gastroenterol Hepatol 2020;32:1348-51. [PMID: 31895913 DOI: 10.1097/MEG.0000000000001647] [Reference Citation Analysis]
2 Arribas J, Benito R, Cebollada R, Bellés A, Bueno J, Cumbraos MJ, Gil J. Implications of grey zone results for routine hepatitis C virus screening with the ARCHITECT HCV-Ag assay. J Appl Microbiol 2020;128:899-906. [PMID: 31713922 DOI: 10.1111/jam.14517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Kim MH, Kang SY, Lee WI, Lee MY. Evaluation of HCV RNA by PCR and Signal-to-Cutoff Ratios of HCV Antibody Assays for Diagnosis of HCV Infection. Lab Med 2021;52:240-4. [PMID: 32895701 DOI: 10.1093/labmed/lmaa074] [Reference Citation Analysis]
4 Wang L, Lv H, Zhang G. Hepatitis C virus core antigen assay: an alternative method for hepatitis C diagnosis. Ann Clin Biochem 2017;54:279-85. [PMID: 27614354 DOI: 10.1177/0004563216661218] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]